Cavitation Technologies delays Form 10-Q filing

Cavitation Technologies, Inc. has submitted a Form 12b-25 notification saying it could not timely file its Form 10-Q for the period ended March 31, 2026.

Rhea-AI Filing Summary

Cavitation Technologies, Inc. has submitted a Form 12b-25 notification saying it could not timely file its Form 10-Q for the period ended March 31, 2026. The company states it "was not able to complete timely its financial statements without unreasonable effort or expense."

The filing identifies Naum Voloshin as the contact and provides a telephone number. The notification reserves any specific timing or quantitative updates about results for the forthcoming report.

Insights

Compliance Officer

12b-25 signals a short delay in periodic reporting due to financial statement completion issues.

The submission states the registrant "was not able to complete timely its financial statements without unreasonable effort or expense," invoking Rule 12b-25. This is a formal notification that permits up to a limited cure period under the rule.

Key dependencies include completion of audited or reviewed financial schedules and any required auditor exhibit under Rule 12b-25(c). Subsequent periodic filings will show whether the issue was resolved within the cure period.

Key Figures

Form type: Form 12b-25 (NT 10-Q) Period ended: March 31, 2026 Contact telephone: 818 718-0905 +1 more

4 metrics

Form type Form 12b-25 (NT 10-Q) Notification of late Form 10-Q

Period ended March 31, 2026 affected reporting period

Contact telephone 818 718-0905 Naum Voloshin

Reason for delay Could not complete financial statements "without unreasonable effort or expense"

Key Terms

Rule 12b-25, Form 10-Q, financial statements

3 terms

Rule 12b-25 regulatory

"The subject report could not be filed without unreasonable effort or expense"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-Q financial

"Notification of late filing for the period ended March 31, 2026"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

financial statements financial

""was not able to complete timely its financial statements without unreasonable effort or expense""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Cavitation Technologies (CVAT) file a Form 12b-25?

The company states it "was not able to complete timely its financial statements without unreasonable effort or expense," which is the reason given for the late Form 10-Q filing.

Which reporting period is affected by the late filing for CVAT?

The notification covers the periodic report for the period ended March 31, 2026, identifying that Form 10-Q for that period could not be filed on time.

Who is the contact for questions about CVAT's late filing?

The company lists Naum Voloshin as the contact and provides the telephone number 818 718-0905 for inquiries regarding this notification.

Does the Form 12b-25 state when the late Form 10-Q will be filed?

The filing does not include a specific filing date; it states the registrant could not complete its financial statements in time and will file the subject report when those statements are complete.

Does the notification indicate whether prior periodic reports are up to date for CVAT?

The form includes the standard question about prior periodic reports filed in the past 12 months, but the excerpt does not state an affirmative or negative response to that question.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 01:30 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One) ☐ Form 10-K    ☐ Form 20-F   ☐ Form 11-K   ☒ Form 10-Q   ☐ Form 10-D  ☐ Form N-CEN       ☐ Form N-CSR

For Period Ended: March 31, 2026

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended: ________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Cavitation Technologies, Inc.

Full Name of Registrant:

Former Name if Applicable

10019 Canoga Avenue

Address of Principal Executive Office (Street and Number)

Chatsworth, CA 91311

City, State, Zip Code

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof could not be filed within the prescribed time period.

The Registrant is unable to file the subject report in a timely manner because the Registrant was not able to complete timely its financial statements without unreasonable effort or expense.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

Naum Voloshin		818		718-0905
(Name)		(Area Code)		(Telephone No.)

(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Cavitation Technologies, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 14, 2026 By: /s/ Naum Voloshin             Title: President; CFO and Member of Board of Directors

2